You are here: Industry Insights > API

News List

CordenPharma Colorado Completes Highly Potent API Lab Expansion contractpharma
October 21, 2020
CordenPharma has completed a new highly potent active pharmaceutical ingredient (API) laboratory in its Boulder, CO, facility.
Biopharma companies more optimistic about 2020 imports/exports than in Q1: GlobalData expresspharma
October 19, 2020
API manufacturing still remains a greater concern than finished dose due to the high volume of small molecule API produced in China and India for cost reasons.
More than APIs, Indian pharma industry needs to reduce dependency on drug intermediates: Premchand Godha expresspharma
October 10, 2020
Policies, schemes should be designed keeping overall drug industry in mind, said the Chairman and MD of Ipca Laboratories.
Majority of generic drug ingredients produced in Asia – study expresspharma
October 10, 2020
Industry players warn bringing production home may be a complicated process, saying higher labour costs and tougher environmental standards make it impossible to compete with Asian suppliers on price.
Research finds 25 percent of drugs contain highly potent compounds europeanpharmaceuticalreview
September 27, 2020
A new report has said that a quarter of drugs globally are based on highly potent active pharmaceutical ingredients.
India ramping up API manufacturing: NITI Aayog CEO expresspharma
September 17, 2020
Indian government is committed to achieving its ''Pharma Vision 2020'', which aims to make the country a global leader in drug discovery, innovation, and drug manufacturing, said Kant.
CORONA Remedies picks up stake in La Chandra Pharmalab expresspharma
September 08, 2020
La Chandra Pharmalab is a manufacturer and supplier of pregnancy care drug progesterone and a range of hormone APIs.
Piramal to Deliver Integrated Services to Epirium contractpharma
August 28, 2020
Includes formulation development, supply of APIs and intermediates, chemistry development and manufacturing, and solid oral dosage form drug product.
NPPA rejects IPA request for upward price revision of five per cent on all drugs expresspharma
August 20, 2020
According to DEA analysis concluded that some spike in import prices of certain APIs have been witnessed in the post-COVID-19 period, but it does not validate the claim of IPA for a price increase.
India’s CMO market is hotbed for global PE investment: GlobalData expresspharma
August 18, 2020
Indian pharma companies are more likely to engage in contract/excess capacity API manufacture than companies in the other small molecule API hotspots such as in the US and China.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page